148 related articles for article (PubMed ID: 8833394)
1. The neural cell adhesion molecule NCAM in multiple myeloma.
Kaiser U; Auerbach B; Oldenburg M
Leuk Lymphoma; 1996 Feb; 20(5-6):389-95. PubMed ID: 8833394
[TBL] [Abstract][Full Text] [Related]
2. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
[TBL] [Abstract][Full Text] [Related]
4. Serum neural cell adhesion molecule in multiple myeloma and other plasma cell disorders.
Smith SR; Auerbach B; Morgan L
Br J Haematol; 1996 Jan; 92(1):67-70. PubMed ID: 8562413
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.
Ely SA; Knowles DM
Am J Pathol; 2002 Apr; 160(4):1293-9. PubMed ID: 11943714
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression of the neural cell adhesion molecule (N-CAM) in a panel of multiple myeloma cell lines.
De Greef C; Van Riet I; Bakkus MH; Van Camp B
Leukemia; 1998 Jan; 12(1):86-93. PubMed ID: 9436925
[TBL] [Abstract][Full Text] [Related]
7. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
8. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma.
Yoshida T; Ri M; Kinoshita S; Narita T; Totani H; Ashour R; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
PLoS One; 2018; 13(5):e0196780. PubMed ID: 29738534
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses.
Ioannou MG; Stathakis E; Lazaris AC; Papathomas T; Tsiambas E; Koukoulis GK
Pathol Oncol Res; 2009 Mar; 15(1):25-9. PubMed ID: 18553158
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
[TBL] [Abstract][Full Text] [Related]
12. Expression of neural cell adhesion molecule and polysialic acid in human bone marrow-derived mesenchymal stromal cells.
Skog MS; Nystedt J; Korhonen M; Anderson H; Lehti TA; Pajunen MI; Finne J
Stem Cell Res Ther; 2016 Aug; 7(1):113. PubMed ID: 27528376
[TBL] [Abstract][Full Text] [Related]
13. CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome.
Koumpis E; Tassi I; Malea T; Papathanasiou K; Papakonstantinou I; Serpanou A; Tsolas E; Kapsali E; Vassilakopoulos TP; Papoudou-Bai A; Hatzimichael E
Pathol Res Pract; 2021 Sep; 225():153567. PubMed ID: 34352440
[TBL] [Abstract][Full Text] [Related]
14. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma.
Pellat-Deceunynck C; Barillé S; Jego G; Puthier D; Robillard N; Pineau D; Rapp MJ; Harousseau JL; Amiot M; Bataille R
Leukemia; 1998 Dec; 12(12):1977-82. PubMed ID: 9844928
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells.
Perl AK; Dahl U; Wilgenbus P; Cremer H; Semb H; Christofori G
Nat Med; 1999 Mar; 5(3):286-91. PubMed ID: 10086383
[TBL] [Abstract][Full Text] [Related]
16. [The impact of polysialic acid (PSA) and polysialylated neural cell adhesion molecule (PSA-NCAM) on tumor and cell signaling pathways].
Wang X; Guan F
Yi Chuan; 2014 Aug; 36(8):739-46. PubMed ID: 25143271
[TBL] [Abstract][Full Text] [Related]
17. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
[TBL] [Abstract][Full Text] [Related]
18. C-kit ligand (SCF) in human multiple myeloma cells.
Lemoli RM; Fortuna A
Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
[TBL] [Abstract][Full Text] [Related]
19. Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
Wachowiak R; Rawnaq T; Metzger R; Quaas A; Fiegel H; Kähler N; Rolle U; Izbicki JR; Kaifi J; Till H
Pediatr Surg Int; 2008 Dec; 24(12):1361-4. PubMed ID: 18972120
[TBL] [Abstract][Full Text] [Related]
20. The role of adhesion molecules in multiple myeloma.
Barker HF; Ball J; Drew M; Hamilton MS; Franklin IM
Leuk Lymphoma; 1992 Oct; 8(3):189-96. PubMed ID: 1490146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
